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In this issue of Osteoarthritis and Cartilage, Abram and coworkers report an increase in the 
proportion of patients undergoing knee arthroplasty (TKR) within 1 or 2 years of arthroscopic 
partial meniscectomy (APM)
1
. The proportion of patients, all in care funded by the National 
Health Service in England, undergoing TKR within 1 year of APM increased by 141% between 
1997 and 2016. The authors noted particularly high rates of TKR conversion for patients over 
the age of sixty years, with a 1-year rate of APM to TKR conversion of 10% and a 2-year rate 
of 17%. There was a ten-fold variation in the conversion rate between healthcare regions. 
The obtained estimates on the incidence of TKR conversion after APM are aligned with the 




So why is it in this context important to get it right the first time, that is, to begin by choosing 
the right treatment for the right patient at the right time? 
 
There is no clinically relevant benefit of arthroscopic surgery over a structured exercise 
program or sham surgery in the middle-aged or older patient with knee pain
3
. More 
specifically, arthroscopic debridement and lavage provide no benefit over that of sham 
surgery for patients with knee OA, and APM has been shown not to provide any clinically 
relevant benefit over sham surgery, or a structured exercise program, for the middle-aged or 
older patient with knee pain. The high rates of TKR conversion for patients over the age of 
sixty years is particularly troubling, as we have known for years that arthroscopic surgery for 
knee pain is least effective in patients with osteoarthritis, and the older one gets, the higher 
















Of further concern, an observational study showed that APM in this patient group was 
associated with an increased risk for progression of radiographic OA
4
. In this nested case-
control study based on the Osteoarthritis Initiative, the authors reported that partial 
meniscectomy was strongly associated with incident radiographic OA within 1 year, and with 
an increased risk of worsening cartilage damage, compared to the matched group without 
meniscectomy. Importantly, these observational study results were confirmed in a follow-up 
MRI analysis of the MeTeOR randomized trial comparing arthroscopic partial meniscectomy 
with physical therapy for patients with knee OA and a meniscal tear
5
. Patients undergoing 
APM had greater advancement of MRI-based OA markers over 18 months than those 
treated non-operatively. 
 
A widely held contention among frontline practitioners is that within the overall population 
included in the randomized trials to date, subgroups may exist that could benefit from APM
6
. 
However, low-risk-of-bias evidence for the existence of subgroups with a more favorable 
outcome is lacking, while secondary analyses of RCTs speak against the existence of such 
subgroups
3,7-9
. These studies found no evidence to support the prevailing ideas that patients 
with mechanical symptoms, acute onset of symptoms, certain meniscus tear characteristics 
or those who have failed initial conservative treatment – the subgroups most commonly 
argued to be optimal candidates – would be more likely to benefit from APM.  
 
How should we interpret the finding that almost 1 out of every 5 patients who undergoes 
APM ends up having TKR within 2 years of the index surgery? In their publication
1
, the 
authors argue that “Knee arthroplasty may be considered the undesirable outcome of end-















was performed in a patient with already advanced osteoarthritis, or that the outcome 
following APM was characterized by rapidly progressive osteoarthritis”. For most medical, 
non-lifesaving interventions, an almost 20% failure rate within 2 years after the delivery of 
the intervention would be a cause for serious concern. 
 
What could be the possible explanations for the 10-fold variation in the services provided? 
Some of this is likely to be attributable to actual between-regions differences in the 
prevalence of the OA disease per se and demographics. However, this would explain only a 
minor part of the 10-fold variation. A recent study assessing the extent of geographical 
variation across musculoskeletal surgical procedures and associated factors in Ireland 
showed that there was minimal variation in hip fracture care while elective hip, knee and 
spinal procedures – those with the most ambiguous, ‘relative’ indications – showed highest 




Findings like these might amplify demands to curtail the autonomy of the orthopedic 
surgeons in defining the indications for their surgeries. Frontline practitioners have recently 
issued a consensus statement concluding that knee arthroscopy/APM is still a valid 
procedure if and when patients are chosen correctly
11
. We would not want to discourage a 
clearly genuine effort to facilitate the consistent identification and treatment of patients 
with meniscal lesions, but note that the latest evidence suggests that this effort might turn 
out to be a tall order. A recent study that set out to identify those most likely to benefit from 
APM failed to identify any subgroups of patients with certain characteristics having a 
favorable outcome at 1 year following meniscal surgery, despite combining a large number 
of preoperative factors presumed clinically relevant
12















survey carried out on 194 orthopaedic surgeons and residents in the Netherlands and 
Australia – based on the actual patient cases of the ESCAPE trial
13
 – showed that orthopedic 
surgeons’ predictions of outcome from APM in patients with non-obstructive meniscal tears 
were no better than prediction expected by chance alone, regardless of level of clinical 
experience
14
. We applaud the arthroscopy consensus statement in concluding that 
validation [of the introduced concepts] in clinical practice is now required and several areas 





Unsustainable growth in healthcare expenditure demands effective cost-containment 
policies. Medical overuse has already resulted in healthcare costs outstripping GDP-growth 
with diminishing returns in population health. Even care that is apparently high quality, safe, 
efficient, and cost-effective in other circumstances, will decrease in value when delivered to 
the wrong patient at the wrong time. The outlook becomes grimmer when the efficacy of 
the intervention is highly questionable. This is the case regarding APM for patients with 
‘degenerative’ knee disease. 
 
Consistent low-risk-of-bias evidence shows that first-line treatment for the middle-aged or 
older patient with knee pain should be education, a structured exercise program, and where 
appropriate, referral to a weight-control program
3,15
. Getting it right first time, this would 
markedly decrease a perceived need for APM. As a bonus, this may also decrease some of 


















For all the dark clouds looming over the practice of knee arthroscopy in patients with knee 
pain and ‘degenerative’ knee disease, there seems to be some light at the end of the tunnel. 
Medical reversals are painstakingly difficult
17
. However, orthopedic surgeons are to be 
praised for their exceptional character and self-esteem in accepting the inevitable and for 
their collective courage in abandoning prior faulty beliefs: During the past few years, we 
have witnessed a decline in the rates of arthroscopies and meniscectomies in many 
European countries and even in the US
3,18
. This makes orthopedic surgeons stand out from 
most other medical specialist groups. 
 
Striving to get it right first time, Abrams and colleagues conclude by recommending the 
development and adoption of national treatment guidance for arthroscopic meniscal surgery 
to improve and standardize treatment selection
1,19
. Although we highly commend this 
initiative, we encourage them to aim higher: There appears to be an urgent need to 
implement processes to reduce inappropriate arthroscopic knee surgery in the UK. A 





















1. Abram SGF, Judge A, Beard D, Price A. Rates of knee arthroplasty within one-year of 
undergoing arthroscopic partial meniscectomy in England: temporal trends, regional 
and age-group variation in conversion rates. Osteoarthritis Cartilage 2019; in press 
(this issue). 
2. Winter AR, Collins JE, Katz JN. The likelihood of total knee arthroplasty following 
arthroscopic surgery for osteoarthritis: a systematic review. BMC Musculoskelet 
Disord 2017; 18: 408. 
3. Siemieniuk RAC, Harris IA, Agoritsas T, Poolman RW, Brignardello-Petersen R, Van de 
Velde S, et al. Arthroscopic surgery for degenerative knee arthritis and meniscal tears: 
a clinical practice guideline. BMJ 2017; 357: j1982. 
4. Roemer FW, Kwoh CK, Hannon MJ, Hunter DJ, Eckstein F, Grago J, et al. Partial 
meniscectomy is associated with increased risk of incident radiographic osteoarthritis 
and worsening cartilage damage in the following year. Eur Radiol 2017; 27: 404-413. 
5. Collins JE, Losina E, Marx RG, Guermazi A, Jarraya M, Jones MH, et al. Early MRI-based 
Changes in Patients with Meniscal Tear and Osteoarthritis. Arthritis Care Res 
(Hoboken) 2019; in press. 
6. Abram SGF, Hopewell S, Monk AP, Bayliss LE, Beard DJ, Price AJ. Arthroscopic partial 
meniscectomy for meniscal tears of the knee: a systematic review and meta-analysis. 
Br J Sports Med 2019; 0: 1–13. doi:10.1136/bjsports-2018-100223. 
7. Thorlund JB, Juhl CB, Roos EM, Lohmander LS. Arthroscopic surgery for degenerative 
knee: systematic review and meta-analysis of benefits and harms. BMJ 2015; 350: 
h2747. 
8. Kise NJ, Risberg MA, Stensrud S, Ranstam J, Engebretsen L, Roos EM. Exercise therapy 
versus arthroscopic partial meniscectomy for degenerative meniscal tear in middle 
aged patients: randomised controlled trial with two year follow-up. BMJ 2016; 354: 
i3740. 
9. Sihvonen R, Paavola M, Malmivaara A, Itala A, Joukainen A, Nurmi H, et al. 
Arthroscopic partial meniscectomy versus placebo surgery for a degenerative 
meniscus tear: a 2-year follow-up of the randomised controlled trial. Ann Rheum Dis 
2018; 77: 188-195. 
10. Walsh ME, Boland F, O'Byrne JM, Fahey T. Geographical variation in musculoskeletal 
surgical care in public hospitals in Ireland: a repeated cross-sectional study. BMJ Open 
2019; 9: e028037. 
11. Abram SGF, Beard DJ, Price AJ, Group BMW. Arthroscopic meniscal surgery: a national 
society treatment guideline and consensus statement. Bone Joint J 2019; 101-B: 652-
659. 
12. Pihl K, Ensor J, Peat G, Englund M, Lohmander S, Jorgensen U, et al. Wild-goose chase, 
no predictable patient subgroups who benefit from meniscal surgery: patient-reported 
outcomes of 641 patients 1 year after surgery. Br J Sports Med 2019; 0: 1–11. 
doi:10.1136/bjsports-2018-100321. 
13. van de Graaf VA, Noorduyn JCA, Willigenburg NW, Butter IK, de Gast A, Mol BW, et al. 
Effect of Early Surgery vs Physical Therapy on Knee Function Among Patients With 
Nonobstructive Meniscal Tears: The ESCAPE Randomized Clinical Trial. JAMA 2018; 
320: 1328-1337. 
14. van de Graaf VA, Bloembergen CH, Willigenburg NW, Noorduyn JCN, Saris DBF, Harris 















surgery in treatment in patients with degenerative meniscal tears? A survey of 194 
orthopaedic surgeons who made 3880 predictions. Br J Sports Med 2019; In Press. 
15. Skou ST, Roos EM. Good Life with osteoArthritis in Denmark (GLA:D): evidence-based 
education and supervised neuromuscular exercise delivered by certified 
physiotherapists nationwide. BMC Musculoskelet Disord 2017; 18: 72. 
16. Skou ST, Roos EM, Laursen MB, Rathleff MS, Arendt-Nielsen L, Simonsen O, Rasmussen 
S. A randomized, controlled trial for total knee replacement. New Engl J Med 2015; 
373: 1597-1606. 
17. Prasad V, Ioannidis JP. Evidence-based de-implementation for contradicted, unproven, 
and aspiring healthcare practices. Implement Sci 2014; 9: 1. 
18. Howard DH. Trends in the Use of Knee Arthroscopy in Adults. JAMA Intern Med 2018; 
178: 1557-1558. 
19. https://www.boa.ac.uk/standards-guidance/getting-it-right-first-time.html . Accessed 
July 4, 2019. 
20. Chen HY, Harris IA, Sutherland K, Levesque JF. A controlled before-after study to 
evaluate the effect of a clinician led policy to reduce knee arthroscopy in NSW. BMC 
Musculoskelet Disord 2018; 19: 148. 
 
